Validation of a Novel Modified Aptamer-Based Array Proteomic Platform in Patients with End-Stage Renal Disease

End stage renal disease (ESRD) is characterized by complex metabolic abnormalities, yet the clinical relevance of specific biomarkers remains unclear. The development of multiplex diagnostic platforms is creating opportunities to develop novel diagnostic and therapeutic approaches. SOMAscan is an in...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Zhongji, Xiao, Zhousheng, Kalantar-Zadeh, Kamyar, Moradi, Hamid, Shafi, Tariq, Waikar, Sushrut S., Quarles, L. Darryl, Yu, Zhi, Tin, Adrienne, Coresh, Josef, Kovesdy, Csaba P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316431/
https://www.ncbi.nlm.nih.gov/pubmed/30297602
http://dx.doi.org/10.3390/diagnostics8040071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316431/
https://www.ncbi.nlm.nih.gov/pubmed/30297602
http://dx.doi.org/10.3390/diagnostics8040071

Ejemplares similares